- Home
- BDRX vs CELZ Comparison
BDRX vs CELZ Comparison
Compare BDRX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- CELZ
- Stock Information
- Founded
- BDRX 2000
- CELZ 1998
- Country
- BDRX United Kingdom
- CELZ United States
- Employees
- BDRX N/A
- CELZ N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- CELZ Health Care
- Exchange
- BDRX Nasdaq
- CELZ Nasdaq
- Market Cap
- BDRX 5.8M
- CELZ 5.5M
- IPO Year
- BDRX N/A
- CELZ N/A
- Fundamental
- Price
- BDRX $0.90
- CELZ $2.68
- Analyst Decision
- BDRX
- CELZ
- Analyst Count
- BDRX 0
- CELZ 0
- Target Price
- BDRX N/A
- CELZ N/A
- AVG Volume (30 Days)
- BDRX 3.2M
- CELZ 84.5K
- Earning Date
- BDRX 04-11-2025
- CELZ 08-08-2025
- Dividend Yield
- BDRX N/A
- CELZ N/A
- EPS Growth
- BDRX N/A
- CELZ N/A
- EPS
- BDRX N/A
- CELZ N/A
- Revenue
- BDRX N/A
- CELZ $14,000.00
- Revenue This Year
- BDRX N/A
- CELZ N/A
- Revenue Next Year
- BDRX N/A
- CELZ N/A
- P/E Ratio
- BDRX N/A
- CELZ N/A
- Revenue Growth
- BDRX N/A
- CELZ 55.56
- 52 Week Low
- BDRX $0.78
- CELZ $1.69
- 52 Week High
- BDRX $41.50
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- BDRX 39.25
- CELZ 71.60
- Support Level
- BDRX $0.85
- CELZ $2.36
- Resistance Level
- BDRX $0.97
- CELZ $2.89
- Average True Range (ATR)
- BDRX 0.11
- CELZ 0.24
- MACD
- BDRX -0.00
- CELZ 0.05
- Stochastic Oscillator
- BDRX 28.24
- CELZ 87.80
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.